Governor Maura Healey of Massachusetts announced on May 19, 2026, the appointment of three new Commissioners to the state’s Cannabis Control Commission (CCC), an agency central to Massachusetts cannabis regulation. These appointments follow the signing of comprehensive cannabis reform legislation last month, which aims to strengthen oversight, improve accountability, and support the continued development of the state’s cannabis industry.
The newly appointed Commissioners are Christopher Harding, designated as Chair, Xiomara DeLobato, and Anthony Wilson. Governor Healey stated that the industry contributes significantly to the state’s economy, supporting thousands of jobs and small businesses across Massachusetts. The reforms are intended to establish a regulatory structure that is effective, accountable, and capable of meeting the demands of a growing industry.
Restructuring the Cannabis Control Commission
The recent legislation represents the most substantial update to Massachusetts cannabis policy since the initial legalization framework. A primary component of these reforms is the restructuring of the Cannabis Control Commission itself. Previously a five-member body, the CCC will now operate as a three-member commission.
Crucially, the new law designates the Chair of the CCC as the agency’s Chief Executive Officer (CEO). This change grants the Chair direct authority over day-to-day operations, staffing decisions, and budgeting. This structural modification is designed to create clearer leadership and enhance operational management within the Commission, aiming for increased integrity, stability, and public trust in Massachusetts cannabis regulation.
New Leadership Profiles
- Christopher Harding (Chair): Appointed as Chair, Mr. Harding brings extensive leadership experience from both state government and the private sector. His background includes organizational management, strategic operations, and technology modernization. He currently serves as Chief of Staff and Undersecretary at the Executive Office of Health and Human Services (EOHHS) and previously held the position of Commissioner of the Massachusetts Department of Revenue (DOR). Mr. Harding was also a founding member of the Cannabis Advisory Board, where he chaired the industry subcommittee.
- Xiomara DeLobato (Commissioner): Ms. DeLobato joins the Commission with expertise in social justice, economic development, workforce strategy, and community engagement. She is currently the Vice President and Chief of Staff for the Western Massachusetts Economic Development Council. Her experience across higher education, nonprofit leadership, and public service has focused on expanding opportunities and fostering connections between communities and economic growth, particularly for underserved populations. She has been designated as the Social Equity Commissioner.
- Anthony Wilson (Commissioner): Mr. Wilson contributes extensive experience in cannabis law, municipal government, and small business development. He has advised various cannabis operators, entrepreneurs, and startups on navigating Massachusetts’ regulatory environment. In addition to his private practice, Mr. Wilson has worked with municipalities on economic development and organizational management through UMass Boston and held senior municipal leadership roles in Springfield and Cambridge, including Associate City Solicitor and City Clerk.
Key Regulatory Reforms and Industry Impact
Beyond the structural changes to the CCC, the reform legislation modernizes several aspects of Massachusetts cannabis regulation to better support businesses, workers, and consumers. The key provisions include:
- Expanded Licensing: The law expands retail license caps and authorizes new license categories. These include event-based licenses, research licenses, and limited delivery licenses, aiming to diversify market participation and access.
- Medical Marijuana Updates: Requirements for medical marijuana businesses have been updated, though specific details were not provided in the announcement.
- Financial Accountability: Stronger financial accountability protections have been established to address unpaid business debts within the industry.
- Future Studies: The Commission has been directed to conduct further studies on cannabis use trends, tax policy, and the future regulation of hemp-derived cannabinoid products. This indicates a proactive approach to evolving market dynamics and product categories.
These collective reforms are designed to foster a safer, more transparent, and more competitive cannabis marketplace, reinforcing Massachusetts’ position in cannabis regulation and innovation.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
